A-2022

N/A

Report date: 2025/07/09 20:00:48
NME

Base Information

Drug NameA-2022
Drug Alias NameA-2022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsChemotherapy-induced nausea and vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Pude Kangli Pharmaceutical Technology Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Pude Kangli Pharmaceutical Technology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A